Hints and tips:
....; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...The failed settlement with Apotex, a Canadian generic drugmaker, damaged the company’s profits and reputation just as Bristol appeared to be reviving its image after previous legal problems in Mr Dolan’s...
...cent to $24.04 after it announced that the federal government was conducting an anti-trust investigation into a settlement reached by it and its marketing partner Sanofi-Aventis with generic drug maker Apotex...
...Pharmaceutical stocks also moved broadly higher after drugmaker Bristol-Myers Squibb settled a key patent dispute with Canadian generic drugmaker Apotex....
International Edition